Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Prenetics

Biotech & Life Sciences · Eastern District, Hong Kong · Founded 2014 Unicorn

Aims to give millions of people personalized information about the health of their bodies to help them confidently make choices about their lives

Valuation
$220M
Market cap · May/2026
Revenue
$31M
Latest reported FY

Investors

13 investors on Prenetics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage
500 Global
Groupon
SXE Ventures
COENT Venture Partners
Venturra Capital
Ping An Ventures
Series B+ 7 investors entered at this stage
City University of Hong Kong
Apis Partners
eGarden Ventures
Alibaba Entrepreneurs Fund
mFund
Beyond Ventures
Yuantai Investment Partners

Global footprint

Where Prenetics has talent and traffic

Workforce by country
12 countries with
team presence
🇭🇰 Hong Kong45%
🇲🇾 Malaysia25.5%
🇬🇧 United Kingdom13.7%
🇮🇳 India4.9%
🇺🇸 United States2%
Top 5 of 12 shown
Web traffic by country
39K monthly visits
across markets
🇺🇸 United States13.3%
🇦🇺 Australia11%
🇬🇧 United Kingdom7.4%
🇦🇪 United Arab Emirates6.7%
🇭🇰 Hong Kong6.4%
Top 5 markets shown

Patent intelligence

$13k patent portfolio · 4 active families

Estimated portfolio value
$13k
<0.01% of market cap · 2672.4× smaller than top peer Cue ($36M)
4 active patent families
Where Prenetics innovates Mechanical engineeringPhysicsTest tubeMolecular biologyNucleic acid detection

Where Prenetics concentrates vs peers

Each axis is a top-10 topic across Prenetics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Prenetics's 5 investments and acquisitions.

Every disclosed deal where Prenetics appeared as a backer or acquirer, 2018–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Prenetics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Prenetics deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Prenetics's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        What the market is saying about Prenetics

        An AI-synthesized read of the highest-engagement posts about Prenetics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Prenetics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.